January 18, 2026
Newcastle Gastroenterologist Dr. Chris Lamb Recognized as European Rising Star
Dr. Chris Lamb, honorary gastroenterologist at Newcastle Hospitals and principal investigator at Newcastle University, has been awarded the UEG Rising Star for pioneering inflammatory bowel disease research. His work focuses on gut microbiome-treatment relationships in Crohn’s and ulcerative colitis.
Key Takeaways
UEG Rising Star Award Recognizes Dr. Chris Lamb’s Gastroenterology Research Excellence
The United European Gastroenterology (UEG) awarded Dr. Lamb for his international research track record and scientific independence. The honor highlights his contributions to advancing digestive health science across Europe.
IBD-RESPONSE Study Aims to Link Gut Microbiome to Inflammatory Bowel Disease Treatment Outcomes
As principal investigator, Dr. Lamb leads a UK-wide study analyzing how gut microbiome composition affects responses to IBD treatments. This research could revolutionize personalized treatment timelines for Crohn’s and colitis patients.
NIHR Biomedical Research Centre Emerging Lead for Liver Disease and Multi-Morbidity
Dr. Lamb oversees liver disease research at the National Institute for Health Research, focusing on multi-morbidity challenges. His work addresses overlapping conditions that complicate liver disease management in patients.
Young Gastroenterologist of the Year Award Highlights Dr. Lamb’s Early Career Excellence
Previously honored by the British Society of Gastroenterology, Dr. Lamb demonstrated leadership potential early in his career. His award-winning research emphasizes patient-centered approaches to unmet medical needs in IBD.
Collaboration with Crohn’s and Colitis UK Supports Youth with Bowel Disease
Dr. Lamb partners with Crohn’s and Colitis UK to improve care for young patients. He advocates for academic accessibility, showing how clinical and lab research can be combined to drive patient benefits.
Source: Read full article